Kohei Nakata
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kohei Nakata has a total of 277 co-authors. Here are the top co-authors by number of shared publications:
- Kenoki Ohuchida
Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University
66 shared publications - Masafumi Nakamura
Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University
66 shared publications - Naoki Ikenaga
Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
50 shared publications - Yoshinao Oda
Department of Anatomic Pathology, Pathological Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
50 shared publications - Toshiya Abe
Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
48 shared publications - Bo Zhang
Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
47 shared publications
Latest Publications
- Open Access
- 30 July 2026
- Published by Spandidos Publications in Oncology Letters
- Vol. 32 (4) , 1-2
[Corrigendum] Repositioning of duloxetine to target pancreatic stellate cells
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
- 30 July 2026
- Published by Spandidos Publications in Oncology Letters
- Vol. 32 (4) , 1-2
Open Access[Corrigendum] Repositioning of duloxetine to target pancreatic stellate cells
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S8 from Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint Blockade Sensitivity in Pancreatic Cancer
Top 30 DEGs for three CD8+ T cell clusters identified from scRNA-seq of CD45+ immune cells in KPC1 shNC / shATG7 transplanted syngeneic PDAC tumors
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S8 from Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint Blockade Sensitivity in Pancreatic Cancer
Top 30 DEGs for three CD8+ T cell clusters identified from scRNA-seq of CD45+ immune cells in KPC1 shNC / shATG7 transplanted syngeneic PDAC tumors
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint Blockade Sensitivity in Pancreatic Cancer
Autophagy inhibition in cancer cells triggers T-cell-mediated immune response
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint Blockade Sensitivity in Pancreatic Cancer
Autophagy inhibition in cancer cells triggers T-cell-mediated immune response
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S6 from Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint Blockade Sensitivity in Pancreatic Cancer
Inhibiting autophagy in cancer cells increases the accumulation of intracellular antigens
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint Blockade Sensitivity in Pancreatic Cancer
Inhibiting autophagy in cancer cells increases the accumulation of intracellular antigens
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S6 from Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint Blockade Sensitivity in Pancreatic Cancer
Top 30 DEGs for four DC clusters identified from scRNA-seq of CD45+ immune cells in KPC1 shNC / shATG7 syngeneic PDAC tumors
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S6 from Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint Blockade Sensitivity in Pancreatic Cancer
Top 30 DEGs for four DC clusters identified from scRNA-seq of CD45+ immune cells in KPC1 shNC / shATG7 syngeneic PDAC tumors
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint Blockade Sensitivity in Pancreatic Cancer
Analysis of human PDAC tumors reveals a negative correlation between autophagy in cancer cells and DC activation
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint Blockade Sensitivity in Pancreatic Cancer
Analysis of human PDAC tumors reveals a negative correlation between autophagy in cancer cells and DC activation
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S1 from Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint Blockade Sensitivity in Pancreatic Cancer
Table S1 from Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint Blockade Sensitivity in Pancreatic Cancer
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint Blockade Sensitivity in Pancreatic Cancer
Table S1 from Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint Blockade Sensitivity in Pancreatic Cancer
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S9 from Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint Blockade Sensitivity in Pancreatic Cancer
Triplet therapy comprising CQ, Flt3L, and aLAG3 markedly suppresses tumor growth
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S9 from Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint Blockade Sensitivity in Pancreatic Cancer
Triplet therapy comprising CQ, Flt3L, and aLAG3 markedly suppresses tumor growth
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint Blockade Sensitivity in Pancreatic Cancer
Autophagy inhibition in cancer cells induces the activation of DCs in several murine autophagy-deficient PDAC models
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint Blockade Sensitivity in Pancreatic Cancer
Autophagy inhibition in cancer cells induces the activation of DCs in several murine autophagy-deficient PDAC models
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S7 from Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint Blockade Sensitivity in Pancreatic Cancer
Vaccination experiments with KPC1 shNC/shATG5 and confirmation of the effect of CQ treatment
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint Blockade Sensitivity in Pancreatic Cancer
Vaccination experiments with KPC1 shNC/shATG5 and confirmation of the effect of CQ treatment